Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights
The pathophysiology of Polycystic Ovary Syndrome (PCOS) is quite complex and different
mechanisms could contribute to hyperandrogenism and anovulation, which are the main …
mechanisms could contribute to hyperandrogenism and anovulation, which are the main …
[HTML][HTML] Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …
Complications and challenges associated with polycystic ovary syndrome: current perspectives
S Palomba, S Santagni, A Falbo… - International journal of …, 2015 - Taylor & Francis
Polycystic ovary syndrome (PCOS) represents the most common endocrine dysfunction in
fertile women and it is considered a heterogeneous and multifaceted disorder, with multiple …
fertile women and it is considered a heterogeneous and multifaceted disorder, with multiple …
The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome
The genetic mechanisms underlying functional hyperandrogenism and the polycystic ovary
syndrome (PCOS) remain largely unknown. Given the large number of genetic variants …
syndrome (PCOS) remain largely unknown. Given the large number of genetic variants …
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
BACKGROUND The relation between polycystic ovary syndrome (PCOS) and
cardiovascular disease (CVD) remains unclear. In an attempt to provide high-quality …
cardiovascular disease (CVD) remains unclear. In an attempt to provide high-quality …
The human obesity gene map: the 2004 update
This paper presents the eleventh update of the human obesity gene map, which
incorporates published results up to the end of October 2004. Evidence from single‐gene …
incorporates published results up to the end of October 2004. Evidence from single‐gene …
Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
K Elkind-Hirsch, O Marrioneaux… - The Journal of …, 2008 - academic.oup.com
Context: Insulin resistance and obesity are common features of the polycystic ovary
syndrome (PCOS). Weight loss and use of insulin-lowering drugs have been shown to …
syndrome (PCOS). Weight loss and use of insulin-lowering drugs have been shown to …
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
E Diamanti-Kandarakis, T Paterakis… - Human …, 2006 - academic.oup.com
BACKGROUND: Women with polycystic ovary syndrome (PCOS) have an increased
prevalence of insulin resistance (IR) and related disorders. Elevated serum levels of cellular …
prevalence of insulin resistance (IR) and related disorders. Elevated serum levels of cellular …
Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance
JJ Puder, S Varga, M Kraenzlin… - The Journal of …, 2005 - academic.oup.com
Background: It is controversial whether the polycystic ovary syndrome (PCOS) per se
increases low-grade chronic inflammation and whether this relates to central fat excess. In …
increases low-grade chronic inflammation and whether this relates to central fat excess. In …
Obesity and polycystic ovary syndrome
J Vrbikova, V Hainer - Obesity facts, 2009 - karger.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women
of fertile age. Obesity is encountered in 30–70% of PCOS-affected women, and its presence …
of fertile age. Obesity is encountered in 30–70% of PCOS-affected women, and its presence …